Form 8-K - Current report:
SEC Accession No. 0001641172-25-016785
Filing Date
2025-06-27
Accepted
2025-06-27 06:08:24
Documents
13
Period of Report
2025-06-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 33163
  Complete submission text file 0001641172-25-016785.txt   196441

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ladx-20250611.xsd EX-101.SCH 3017
3 XBRL LABEL FILE ladx-20250611_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ladx-20250611_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3649
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 251082063
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)